MARIA SUAREZ-ALMAZOR to Mass Screening
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Mass Screening.
Connection Strength
0.574
-
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
Score: 0.257
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.101
-
Attitudes toward hepatitis B virus among Vietnamese, Chinese and Korean Americans in the Houston area, Texas. J Community Health. 2012 Oct; 37(5):1091-100.
Score: 0.060
-
Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer. 2011 Dec; 19(12):1921-9.
Score: 0.053
-
Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: whom should we screen? J Am Board Fam Pract. 2005 Sep-Oct; 18(5):355-61.
Score: 0.036
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.023
-
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
Score: 0.018
-
Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract. 2014 May; 10(3):e167-74.
Score: 0.016
-
An absent pulse is not sensitive for the early detection of peripheral arterial disease. Fam Med. 2006 Jan; 38(1):38-42.
Score: 0.009